THE VALIDITY AND REPRODUCIBILITY OF A WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT INSTRUMENT

被引:2192
作者
REILLY, MC [1 ]
ZBROZEK, AS [1 ]
DUKES, EM [1 ]
机构
[1] REILLY ASSOCIATES,WACCABUC,NY
关键词
D O I
10.2165/00019053-199304050-00006
中图分类号
F [经济];
学科分类号
02 ;
摘要
The construct validity of a quantitative work productivity and activity impairment (WPAI) measure of health outcomes was tested for use in clinical trials, along with its reproducibility when administered by 2 different methods. 106 employed individuals affected by a health problem were randomised to receive either 2 self-administered questionnaires (self administration) or one self-administered questionnaire followed by a telephone interview (interviewer administration). Construct validity of the WPAI measures of time missed from work, impairment of work and regular activities due to overall health and symptoms, were assessed relative to measures of general health perceptions, role (physical), role (emotional), pain, symptom severity and global measures of work and interference with regular activity. Multivariate linear regression models were used to explain the variance in work productivity and regular activity by validation measures. Data generated by interviewer-administration of the WPAI had higher construct validity and fewer omissions than that obtained by self-administration of the instrument. All measures of work productivity and activity impairment were positively correlated with measures which had proven construct validity. These validation measures explained 54 to 64% of variance (p < 0.0001) in productivity and activity impairment variables of the WPAI. Overall work productivity (health and symptom) was significantly related to general health perceptions and the global measures of interference with regular activity. The self-administered questionnaire had adequate reproducibility but less construct validity than interviewer administration. Both administration methods of the WPAI warrant further evaluation as a measure of morbidity.
引用
收藏
页码:353 / 365
页数:13
相关论文
共 14 条
  • [1] Bombardier C., Ware J., Russell I.J., Larson M., Chalmers A., Et al., Auranofin therapy and quality of lift in patients with rheumatoid arthritis, American Journal of Medicine, 81, pp. 565-578, (1986)
  • [2] Croog S.H., Levine S., Testa M.A., Brown B., Bulpitt C.J., Et al., The effects of antihypertensive therapy un the quality of life, New England Journal of Medicine, 114, pp. 1657-1664, (1986)
  • [3] Freund D.A., Dittus R.S., Principles of pharmacoeconomic analysis of drug therapy, PharmacoEconomics, 1, pp. 20-32, (1992)
  • [4] Gilson B.S., Erickson D., Chavez C.T., Bobbitt R.A., Bergner M., Et al., A Chicano version of the Sickness Impact Profile (SIP), Culture Medicine Psychiatry, 4, pp. 137-150, (1980)
  • [5] Guyatt G.H., Walter S., Norman G., Measuring change over time: assessing the usefulness of evaluative instruments, Journal of Chronic Diseases, 4, pp. 171-178, (1987)
  • [6] Guyatt G.H., Deyo R.A., Charlson M., Levine M.N., Mitchell A., Responsiveness and validity in health status measurement: a clarification, Journal of Clinical Epidemiology, 42, pp. 403-408, (1987)
  • [7] Kruskall W.H., Wallis W.A., Use of ranks in one-criterion analysis of variance, Journal of the American Statistical Association, 47, pp. 583-621, (1952)
  • [8] Laupacis A., Feeney D., Detsky A.S., Tugwell P.X., How attractive does a new technology have to he to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations, Canadian Medical Association Journal, 146, pp. 473-481, (1992)
  • [9] Lipscomb J., Time preference for health in cost-effectiveness analysis, Medical Care, 27, (1989)
  • [10] O'Toole B.I., Battistutta D., Long A., Crouch K., A comparison of costs and data quality of three health survey methods: mail, telephone and personal home interview, American Journal of Epidemiology, 124, pp. 317-328, (1986)